Acadia Pharmaceuticals Inc (ACAD)
Cost of Revenue
$28.32M
Quarterly · Period ending: · USD
ACAD Cost of Revenue
Latest reported$28.32Mperiod ending
Latest reported$28.32Mperiod ending
ACAD Quarterly Cost of Revenue ($0.00 → $28.32M)
Quarterly cost of revenue
High-resolution chart · PNG
ACAD cost of revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 28,316,000 | |
| 24,791,000 | |
| 26,225,000 | |
| 21,647,000 | |
| 20,734,000 | |
| 20,392,000 | |
| 21,803,000 | |
| 18,857,000 | |
| 18,230,000 | |
| 22,951,000 | |
| 17,891,000 | |
| 14,622,000 | |
| 7,459,000 | |
| 1,667,000 | |
| 2,413,000 | |
| 2,136,000 | |
| 2,667,000 | |
| 2,950,000 | |
| 2,561,000 | |
| 6,682,000 | |
| 5,206,000 | |
| 4,692,000 | |
| 5,301,000 | |
| 4,801,000 | |
| 5,474,000 | |
| 4,974,000 | |
| 5,334,000 | |
| 4,689,000 | |
| 4,995,000 | |
| 4,580,000 | |
| 4,392,000 | |
| 5,375,000 | |
| 5,078,000 | |
| 3,485,000 | |
| 3,703,000 | |
| 3,213,000 | |
| 3,206,000 | |
| 2,938,000 | |
| 2,312,000 | |
| 1,320,000 | |
| 774,000 | |
| 22,775,000 | |
| 22,966,000 | |
| 18,729,000 | |
| 18,379,000 | |
| 16,295,000 | |
| 18,182,000 | |
| 16,952,000 | |
| 13,799,000 | |
| 11,668,000 | |
| 7,925,000 | |
| 7,254,000 | |
| 7,112,000 | |
| 4,430,000 | |
| 4,901,000 | |
| 4,400,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |